Clinical Trial Update: To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating the efficacy and safety of LO2A Eye Drops for conjunctivochalasis, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctivochalasis

Drugs mentioned

• LO2A Eye Drops

Snippet

Sponsor: Ocuwize LTD | Conditions: Conjunctivochalasis | Phase 2 | Status: COMPLETED